Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - TOTAL EQUITY
Total Equity ALLO - Allogene Therapeutics, Inc.
512 M
LAST VALUE
-25.24%
2 YEAR CAGR
-6.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR